Iris Neovascularization

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2008-09-04
Clinical Trial Update: A Pilot Study for the Treatment of Iris Neovascularization With Macugen [Phase 1]
Phase 1 pilot study evaluating pegaptanib (Macugen) for iris neovascularization related to diabetic retinopathy.